Skip to search formSkip to main contentSkip to account menu

OPC-1085

Known as: OPC 1085, OPC1085 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CarteololCarteolol Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Cardiac Electrophysiologic Action of Carteolol Hydrochloride (OPC‐1085), a New Beta‐Adrenergic Blocking Agent *
Cardiac electrophysiologic action of a new beta‐adrenergic blocking agent carteolol hydro‐chloride, or OPC‐1085, was studied in… 
1977
1977
Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
The pharmacokinetics of 5-(3-tert.-butylamino-2-hydroxy)-propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol hydrochloride… 
1977
1977
[Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic blocking agent. (6) Pharmacokinetics of carteolol in the rat, dog, rabbit and man].
The kinetics (absorption, distribution and excretion) of carteolol were investigated after oral and intravenous administration to… 
1977
1977
ANTIARRHYTHMIC PROPERTIES OF 5‐(3‐TERT‐BUTYLAMINO‐2‐HYDROXY)PROPOXY‐3,4‐DIHYDRO‐CARBOSTYRIL HYDROCHLORIDE (OPC‐ 1085), A NEWLY SYNTHESIZED, POTENT β‐ADRENORECEPTOR ANTAGONIST
1. The antiarrhythmic properties of 5–(3‐tert‐butylarnino‐2‐hydroxy)propoxy‐3,4‐dihydrocarbostyril hydrochloride (OPC‐1085) were… 
1977
1977
A comparative study of the effects of OPC-1085 and propranolol on isolated guinea pig atrium.
Effects of a newly synthesized beta-blocker, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril (OPC-1085) were… 
1977
1977
[A comparison of the effects of the beta-adrenergic blockers, carteolol (OPC-1085), propranolol and alprenolol on isolated rat cardiac muscles (author's transl)].
The effects of carteolol, propranolol and alprenolol were studied by using spontaneously contracting atria, atrial muscle and… 
1977
1977
[Metabolic fate of carteolol hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride, OPC-1085], a new beta-blocker. V. Identification of metabolites in rat, dog…
1977
1977
[Fluorometric determination of 5-(3-tert-butylamino-2hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085) and structure of fluorescent substance (author's transl)].
1976
1976
[Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic agent. (3) Autoradiographic total body distribution studies in mice].
Distribution of a new beta-adrenergic blocking agent, 3H-carteolol in mice was studied by whole body autoradiography. The… 
Highly Cited
1974
Highly Cited
1974
Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.
The beta-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl-amino-2-hydroxy) propoxy-3,4-dihydrocarbostyril… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)